跳至主要内容
临床试验/CTRI/2025/02/080142
CTRI/2025/02/080142招募中Unknown

Study to evaluate the Efficacy and Safety of nebulization with Adrenaline and 3% Hypertonic saline vs nebulization with 3% Hypertonic saline alone in Acute Bronchiolitis: A Randomized Controlled Trial.

Narayan Medical College and HospitalJamuharSasaram1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2025年2月17日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
132
试验地点
1
主要终点
1-To evaluate the efficacy of nebulization with adrenaline and 3% hypertonic saline vs nebulization with 3% hypertonic saline alone.

研究概览

简要总结

Acute Bronchiolitis is a lower respiratory tract viral infection that primarily affects the small airways(bronchioles).RSV is the most common cause.Bronchiolitis remains a significant cause of respiratory disease during the first 2 years of life.Diagnosis of bronchiolitis is largely clinical.Treatment is mostly supportive such as oxygen supplementation and hydration.Antibiotics have proven to be ineffective.Treatment with nebulized adrenaline with 3% hypertonic saline have found to decrease severity of symptoms in infants with acute viral bronchiolitis as well as shorten the duration of hospitalization.It is simple,seemingly efficient and cost effective with excellent safety profile.Hence,more research is warranted for further confirmation and expansion of data to clarify this potential treatment modality.

研究设计

研究类型
Observational

入排标准

年龄范围
2.00 Month(s) 至 24.00 Month(s)(—)
性别
All

入选标准

  • Admitted patient with a chronological age of 2 months to 24 months, a clinical diagnosis of Acute bronchiolitis and their initial Wang respiratory score will be 3 or higher will be enrolled in this study.

排除标准

  • Attendants not giving consent.
  • Children with prior illness with wheezing.
  • Children with prior use of bronchodilators.
  • Premature infants (<34wks of gestation).
  • Children with congenital heart disease.
  • Children with chronic lung disease.
  • Severe bronchiolitis (either wang CSS >9 or baseline oxygen saturation <85%).

结局指标

主要结局

1-To evaluate the efficacy of nebulization with adrenaline and 3% hypertonic saline vs nebulization with 3% hypertonic saline alone.

时间窗: Evaluation Every 24 Hour

2-To evaluate the safety of nebulization with adrenaline and 3% hypertonic saline vs nebulization with 3% hypertonic saline alone.

时间窗: Evaluation Every 24 Hour

次要结局

  • To evaluate the changes in clinical scoring after nebulization with adrenaline & 3% hypertonic saline vs nebulization with 3% hypertonic saline alone(Evaluation Every 24 Hour.)
  • To evaluate the changes in average length of hospital stay after nebulization with adrenaline & 3% hypertonic saline vs nebulization with 3% hypertonic saline alone(Evaluation every 24 hour)

研究者

发起方
Narayan Medical College and HospitalJamuharSasaram
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Trigunateet Gupta

Narayan Medical College and Hospital

研究点 (1)

Loading locations...

相似试验